(35 days)
Not Found
Not Found
No
The document describes a quality control kit for electrolyte analyzers, which is a chemical reagent product, not a software or imaging device that would typically incorporate AI/ML. There are no mentions of AI, ML, or related concepts.
No
The device is a quality control kit for IV electrolyte testing, not a device used for treating or diagnosing medical conditions in patients.
No
Explanation: The "Intended Use" states that the kit is used to "estimate test imprecision and to detect variation," indicating it is a quality control product for laboratory tests rather than a device used to diagnose a patient's condition.
No
The device description clearly indicates it is a "Quality Control Kit," which is a physical product used for calibrating or verifying the performance of other medical devices (analyzers). It is not described as software.
Based on the provided information, the device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use explicitly states it's for use with "IV trolyte and yers" (likely meant to be "IV electrolyte analyzers") to "estimate test imprecision and to detects variation." This clearly indicates it's a product used in vitro (outside the body) to assess the performance of diagnostic tests.
- Device Description: While brief, "EasyLyte Quality Control Kit" further supports its role in quality control for laboratory testing.
Quality control materials used to verify the accuracy and precision of diagnostic tests performed on patient samples are considered IVDs.
N/A
Intended Use / Indications for Use
EasyLyte Quality Control Kit is intended for use with IV trolyte and yers to estimate test imprecision and to detects variation. eagent
Product codes
JJR
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not Found
Key Metrics
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1660 Quality control material (assayed and unassayed).
(a)
Identification. A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.(b)
Classification. Class I (general controls). Except when intended for use in donor screening tests, quality control materials (assayed and unassayed) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
Image /page/0/Picture/0 description: The image shows the text "DEPARTMENT OF HEALTH & HUMAN SERVICES" in all caps. The text is in a bold, serif font. The text is centered horizontally in the image.
APR 2 7 1999
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
Mr. Photios Makris Director of Quality Assurance Medica Corporation 14 DeAngelo Drive Bedford, Massachusetts 01730
Re: K990971 Trade Name: EasyLyte Quality Control Kit Regulatory Class: I Product Code: JJR Dated: March 19, 1999 Received: March 23, 1999
Dear Mr. Makris:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting vour device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
1
Page 2
Under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88), this device may require a CLIA complexity categorization. To determine if it does, you should contact the Centers for Disease Control and Prevention (CDC) at (770) 488-7655.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4588. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely vours.
Steven Sutman
Steven I. Gutman, M.D. M.B.A. Director Division of Clinical Laboratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
K990971 510(k) Number (if known):
Device Name: EasyLyte Quality Control Kit
Indications For Use:
ssayed EasyLyte Quality Control Kit is intended for use with IV
trolyte and yers to estimate test imrecision and to detects variation. eagent
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Deyice Evaluation (ODE)
Peter E. Nielson
(Division Sign-Off, Division of Clinical Laboratory Devices 1990971 510(k) Number
Prescription Use (Per 21 CFR 801.109)
OR
Over-The-Counter Use